• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

多参数 MRI 在前列腺癌主动监测中的应用：综述与实用方法。

Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.

机构信息

Department of Radiology, Tan Tock Seng Hospital, Singapore.

Department of Urology, Tan Tock Seng Hospital, Singapore.

出版信息

Korean J Radiol. 2021 Jul;22(7):1087-1099. doi: 10.3348/kjr.2020.1224. Epub 2021 Apr 1.

DOI:10.3348/kjr.2020.1224
PMID:33856136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8236356/
Abstract

MRI has become important for the detection of prostate cancer. MRI-guided biopsy is superior to conventional systematic biopsy in patients suspected with prostate cancer. MRI is also increasingly used for monitoring patients with low-risk prostate cancer during active surveillance. It improves patient selection for active surveillance at diagnosis, although its role during follow-up is unclear. We aim to review existing evidence and propose a practical approach for incorporating MRI into active surveillance protocols.

摘要

MRI 已成为前列腺癌检测的重要手段。在疑似前列腺癌患者中，MRI 引导下的活检优于传统的系统活检。MRI 也越来越多地用于监测接受主动监测的低危前列腺癌患者。它改善了主动监测诊断时的患者选择，但在随访期间的作用尚不清楚。我们旨在回顾现有证据，并提出将 MRI 纳入主动监测方案的实用方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/6088cf1b85a4/kjr-22-1087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/82e562c455a8/kjr-22-1087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/8be6c157f44f/kjr-22-1087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/d71ab6d38a25/kjr-22-1087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/a6e4c62cce0b/kjr-22-1087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/6088cf1b85a4/kjr-22-1087-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/82e562c455a8/kjr-22-1087-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/8be6c157f44f/kjr-22-1087-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/d71ab6d38a25/kjr-22-1087-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/a6e4c62cce0b/kjr-22-1087-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c646/8236356/6088cf1b85a4/kjr-22-1087-g005.jpg

相似文献

1
Multiparametric MRI in Active Surveillance of Prostate Cancer: An Overview and a Practical Approach.多参数 MRI 在前列腺癌主动监测中的应用：综述与实用方法。
Korean J Radiol. 2021 Jul;22(7):1087-1099. doi: 10.3348/kjr.2020.1224. Epub 2021 Apr 1.
2
Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.在随访 1 年后，对接受主动监测的低危前列腺癌男性进行连续多参数磁共振成像和磁共振成像引导下活检的价值。
Eur Urol Focus. 2019 May;5(3):407-415. doi: 10.1016/j.euf.2017.12.008. Epub 2018 Jan 10.
3
Magnetic Resonance Imaging-Transrectal Ultrasound Guided Fusion Biopsy to Detect Progression in Patients with Existing Lesions on Active Surveillance for Low and Intermediate Risk Prostate Cancer.磁共振成像-经直肠超声引导融合活检在主动监测低危和中危前列腺癌患者中检测现有病变进展。
J Urol. 2017 Mar;197(3 Pt 1):640-646. doi: 10.1016/j.juro.2016.08.109. Epub 2016 Sep 6.
4
Multiparametric magnetic resonance imaging can exclude prostate cancer progression in patients on active surveillance: a retrospective cohort study.多参数磁共振成像可排除主动监测患者的前列腺癌进展：一项回顾性队列研究。
Eur Radiol. 2020 Nov;30(11):6042-6051. doi: 10.1007/s00330-020-06997-1. Epub 2020 Jun 26.
5
The Efficacy of Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Risk Classification for Patients with Prostate Cancer on Active Surveillance.多参数磁共振成像和磁共振成像靶向活检在主动监测前列腺癌患者风险分类中的疗效。
J Urol. 2016 Aug;196(2):374-81. doi: 10.1016/j.juro.2016.02.084. Epub 2016 Feb 23.
6
Prostate Indeterminate Lesions on Magnetic Resonance Imaging-Biopsy Versus Surveillance: A Literature Review.磁共振成像引导下前列腺活检与监测的不确定病变：文献综述。
Eur Urol Focus. 2019 Sep;5(5):799-806. doi: 10.1016/j.euf.2018.02.012. Epub 2018 Mar 7.
7
Can the Use of Serial Multiparametric Magnetic Resonance Imaging During Active Surveillance of Prostate Cancer Avoid the Need for Prostate Biopsies?-A Systematic Diagnostic Test Accuracy Review.主动监测前列腺癌期间使用系列多参数磁共振成像能否避免前列腺活检的需要？——系统的诊断测试准确性评价。
Eur Urol Oncol. 2021 Jun;4(3):426-436. doi: 10.1016/j.euo.2020.09.002. Epub 2020 Sep 21.
8
Active Surveillance of Prostate Cancer Using Multiparametric Magnetic Resonance Imaging: A Review of the Current Role and Future Perspectives.使用多参数磁共振成像对前列腺癌进行主动监测：当前作用和未来展望的综述。
Med Sci Monit. 2020 Apr 12;26:e920252. doi: 10.12659/MSM.920252.
9
Cost-Effectiveness Analysis and Microsimulation of Serial Multiparametric Magnetic Resonance Imaging in Active Surveillance of Localized Prostate Cancer.成本效益分析和基于微模拟的前列腺癌局部主动监测中序列多参数磁共振成像的应用。
J Urol. 2022 Jul;208(1):80-89. doi: 10.1097/JU.0000000000002490. Epub 2022 Feb 25.
10
Magnetic Resonance Imaging-Ultrasound Fusion Biopsy During Prostate Cancer Active Surveillance.磁共振成像-超声融合引导前列腺癌主动监测活检。
Eur Urol. 2017 Aug;72(2):275-281. doi: 10.1016/j.eururo.2016.08.023. Epub 2016 Aug 29.

引用本文的文献

1
Analysis of the Diagnostic Efficacy and Clinical Utility of Multiparametric MRI in Prostate Cancer Diagnosis.多参数磁共振成像在前列腺癌诊断中的诊断效能及临床应用分析
Cancer Manag Res. 2025 Aug 27;17:1803-1812. doi: 10.2147/CMAR.S543435. eCollection 2025.
2
The dynamic changes in quantitative parameters of diffusion-weighted imaging at different b-values in a prostate cancer mouse model and their correlation with histopathology parameters.前列腺癌小鼠模型中不同b值下扩散加权成像定量参数的动态变化及其与组织病理学参数的相关性
Braz J Med Biol Res. 2025 Aug 29;58:e14527. doi: 10.1590/1414-431X2025e14527. eCollection 2025.
3

本文引用的文献

1
Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy.系统抽样在多参数磁共振成像靶向前列腺活检策略中的价值。
Transl Androl Urol. 2020 Jun;9(3):1501-1509. doi: 10.21037/tau.2019.07.16.
2
Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study.基于磁共振成像的前列腺癌主动监测的 5 年结果：一项大型队列研究。
Eur Urol. 2020 Sep;78(3):443-451. doi: 10.1016/j.eururo.2020.03.035. Epub 2020 Apr 30.
3
The effect of multiplicity of PI-RADS 3 lesions on cancer detection rate of confirmatory targeted biopsy in patients diagnosed with prostate cancer and managed with active surveillance.
The efficacy of prostate health index (PHI) in predicting pathological progression in low-risk localized prostate cancer cases under active surveillance protocol.
前列腺健康指数（PHI）在主动监测方案下预测低风险局限性前列腺癌病例病理进展中的效能。
World J Urol. 2025 Jul 12;43(1):431. doi: 10.1007/s00345-025-05820-0.
4
Multiparametric MRI to Predict Gleason Score Upgrading and Downgrading at Radical Prostatectomy Compared to Presurgical Biopsy.与术前活检相比，多参数磁共振成像预测前列腺癌根治术时Gleason评分的升级和降级
Korean J Radiol. 2025 May;26(5):422-434. doi: 10.3348/kjr.2024.1008. Epub 2025 Mar 21.
5
A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low- to Intermediate-Risk Prostate Cancer: A Tool to Improve Risk Stratification for Active Surveillance?一项关于前列腺特异性膜抗原正电子发射断层扫描（PSMA PET）评估局限性低至中危前列腺癌的系统评价：一种改善主动监测风险分层的工具？
Life (Basel). 2024 Jan 2;14(1):76. doi: 10.3390/life14010076.
6
Development trends and knowledge framework in the application of magnetic resonance imaging in prostate cancer: a bibliometric analysis from 1984 to 2022.磁共振成像在前列腺癌应用中的发展趋势与知识框架：1984年至2022年的文献计量分析
Quant Imaging Med Surg. 2023 Oct 1;13(10):6761-6777. doi: 10.21037/qims-23-446. Epub 2023 Sep 11.
7
MRI-derived radiomics models for diagnosis, aggressiveness, and prognosis evaluation in prostate cancer.基于 MRI 的影像组学模型在前列腺癌中的诊断、侵袭性评估和预后评价。
J Zhejiang Univ Sci B. 2023 Aug 15;24(8):663-681. doi: 10.1631/jzus.B2200619.
8
Could Biparametric MRI Replace Multiparametric MRI in the Management of Prostate Cancer?双参数磁共振成像能否在前列腺癌管理中取代多参数磁共振成像？
Life (Basel). 2023 Feb 7;13(2):465. doi: 10.3390/life13020465.
多PI-RADS 3 病灶对前列腺癌诊断后主动监测患者行确认性靶向活检的癌症检出率的影响。
Urol Oncol. 2020 Jun;38(6):599.e9-599.e13. doi: 10.1016/j.urolonc.2020.03.002. Epub 2020 Apr 4.
4
Prostate Cancer and Prostatic Diseases Best of Asia, 2019: challenges and opportunities.《亚洲前列腺癌与前列腺疾病精粹，2019：挑战与机遇》
Prostate Cancer Prostatic Dis. 2020 Jun;23(2):197-198. doi: 10.1038/s41391-019-0193-7. Epub 2019 Dec 6.
5
Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.主动监测（ASIST）中男性系统活检与磁共振成像及靶向和系统活检的随机研究：活检后 2 年随访。
Eur Urol. 2020 Mar;77(3):311-317. doi: 10.1016/j.eururo.2019.10.007. Epub 2019 Nov 8.
6
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance Initiative.坚持低危前列腺癌的主动监测方案：莫菲特基金会全球行动计划前列腺癌主动监测倡议的结果。
Eur Urol Oncol. 2020 Feb;3(1):80-91. doi: 10.1016/j.euo.2019.08.014. Epub 2019 Sep 26.
7
Prostate Imaging Reporting and Data System 3 Category Cases at Multiparametric Magnetic Resonance for Prostate Cancer: A Systematic Review and Meta-analysis.前列腺影像报告和数据系统 3 类前列腺癌多参数磁共振成像病例：系统评价和荟萃分析。
Eur Urol Focus. 2020 May 15;6(3):463-478. doi: 10.1016/j.euf.2019.06.014. Epub 2019 Jul 4.
8
PI-RADS Steering Committee: The PI-RADS Multiparametric MRI and MRI-directed Biopsy Pathway.PI-RADS 指导委员会：PI-RADS 多参数 MRI 和 MRI 引导活检途径。
Radiology. 2019 Aug;292(2):464-474. doi: 10.1148/radiol.2019182946. Epub 2019 Jun 11.
9
The primacy of multiparametric MRI in men with suspected prostate cancer.多参数 MRI 在疑似前列腺癌男性中的首要地位。
Eur Radiol. 2019 Dec;29(12):6940-6952. doi: 10.1007/s00330-019-06166-z. Epub 2019 Jun 6.
10
Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-analysis.磁共振成像引导靶向活检与系统活检检测前列腺癌的比较：系统评价和荟萃分析。
Eur Urol. 2019 Sep;76(3):284-303. doi: 10.1016/j.eururo.2019.04.043. Epub 2019 May 24.